Cancer Diagnostics Market - Global Outlook and Forecast 2022-2028

January 2022 | 72 pages | ID: CDC5046DC8B2EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Cancer Diagnostics in Global, including the following market information:

Global Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cancer Diagnostics market was valued at 164970 million in 2021 and is projected to reach US$ 230000 million by 2028, at a CAGR of 4.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Platform-based Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cancer Diagnostics include Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, Siemens Healthcare and C.R. Bard. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)

• Platform-based
• Instrument-based

Global Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Others

Global Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cancer Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Becton, Dickinson and Company
• GE Healthcare
• Abbott
• Roche
• Thermo Fisher Scientific
• Agilent Technologies
• Illumina
• Siemens Healthcare
• C.R. Bard

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cancer Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANCER DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Cancer Diagnostics Market Size: 2021 VS 2028
2.2 Global Cancer Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cancer Diagnostics Players in Global Market
3.2 Top Global Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Cancer Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Cancer Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cancer Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cancer Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 Platform-based
  4.1.3 Instrument-based
4.2 By Type - Global Cancer Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Cancer Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global Cancer Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global Cancer Diagnostics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cancer Diagnostics Market Size, 2021 & 2028
  5.1.2 Breast Cancer
  5.1.3 Lung Cancer
  5.1.4 Colorectal Cancer
  5.1.5 Others
5.2 By Application - Global Cancer Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Cancer Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global Cancer Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global Cancer Diagnostics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cancer Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Cancer Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Cancer Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global Cancer Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global Cancer Diagnostics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cancer Diagnostics Revenue, 2017-2028
  6.3.2 US Cancer Diagnostics Market Size, 2017-2028
  6.3.3 Canada Cancer Diagnostics Market Size, 2017-2028
  6.3.4 Mexico Cancer Diagnostics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cancer Diagnostics Revenue, 2017-2028
  6.4.2 Germany Cancer Diagnostics Market Size, 2017-2028
  6.4.3 France Cancer Diagnostics Market Size, 2017-2028
  6.4.4 U.K. Cancer Diagnostics Market Size, 2017-2028
  6.4.5 Italy Cancer Diagnostics Market Size, 2017-2028
  6.4.6 Russia Cancer Diagnostics Market Size, 2017-2028
  6.4.7 Nordic Countries Cancer Diagnostics Market Size, 2017-2028
  6.4.8 Benelux Cancer Diagnostics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cancer Diagnostics Revenue, 2017-2028
  6.5.2 China Cancer Diagnostics Market Size, 2017-2028
  6.5.3 Japan Cancer Diagnostics Market Size, 2017-2028
  6.5.4 South Korea Cancer Diagnostics Market Size, 2017-2028
  6.5.5 Southeast Asia Cancer Diagnostics Market Size, 2017-2028
  6.5.6 India Cancer Diagnostics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cancer Diagnostics Revenue, 2017-2028
  6.6.2 Brazil Cancer Diagnostics Market Size, 2017-2028
  6.6.3 Argentina Cancer Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cancer Diagnostics Revenue, 2017-2028
  6.7.2 Turkey Cancer Diagnostics Market Size, 2017-2028
  6.7.3 Israel Cancer Diagnostics Market Size, 2017-2028
  6.7.4 Saudi Arabia Cancer Diagnostics Market Size, 2017-2028
  6.7.5 UAE Cancer Diagnostics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Becton, Dickinson and Company
  7.1.1 Becton, Dickinson and Company Corporate Summary
  7.1.2 Becton, Dickinson and Company Business Overview
  7.1.3 Becton, Dickinson and Company Cancer Diagnostics Major Product Offerings
  7.1.4 Becton, Dickinson and Company Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.1.5 Becton, Dickinson and Company Key News
7.2 GE Healthcare
  7.2.1 GE Healthcare Corporate Summary
  7.2.2 GE Healthcare Business Overview
  7.2.3 GE Healthcare Cancer Diagnostics Major Product Offerings
  7.2.4 GE Healthcare Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.2.5 GE Healthcare Key News
7.3 Abbott
  7.3.1 Abbott Corporate Summary
  7.3.2 Abbott Business Overview
  7.3.3 Abbott Cancer Diagnostics Major Product Offerings
  7.3.4 Abbott Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.3.5 Abbott Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Cancer Diagnostics Major Product Offerings
  7.4.4 Roche Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Thermo Fisher Scientific
  7.5.1 Thermo Fisher Scientific Corporate Summary
  7.5.2 Thermo Fisher Scientific Business Overview
  7.5.3 Thermo Fisher Scientific Cancer Diagnostics Major Product Offerings
  7.5.4 Thermo Fisher Scientific Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.5.5 Thermo Fisher Scientific Key News
7.6 Agilent Technologies
  7.6.1 Agilent Technologies Corporate Summary
  7.6.2 Agilent Technologies Business Overview
  7.6.3 Agilent Technologies Cancer Diagnostics Major Product Offerings
  7.6.4 Agilent Technologies Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.6.5 Agilent Technologies Key News
7.7 Illumina
  7.7.1 Illumina Corporate Summary
  7.7.2 Illumina Business Overview
  7.7.3 Illumina Cancer Diagnostics Major Product Offerings
  7.7.4 Illumina Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.7.5 Illumina Key News
7.8 Siemens Healthcare
  7.8.1 Siemens Healthcare Corporate Summary
  7.8.2 Siemens Healthcare Business Overview
  7.8.3 Siemens Healthcare Cancer Diagnostics Major Product Offerings
  7.8.4 Siemens Healthcare Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.8.5 Siemens Healthcare Key News
7.9 C.R. Bard
  7.9.1 C.R. Bard Corporate Summary
  7.9.2 C.R. Bard Business Overview
  7.9.3 C.R. Bard Cancer Diagnostics Major Product Offerings
  7.9.4 C.R. Bard Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.9.5 C.R. Bard Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Cancer Diagnostics Market Drivers in Global Market
Table 3. Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Cancer Diagnostics in Global Market
Table 5. Top Cancer Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Becton, Dickinson and Company Corporate Summary
Table 31. Becton, Dickinson and Company Cancer Diagnostics Product Offerings
Table 32. Becton, Dickinson and Company Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. GE Healthcare Corporate Summary
Table 34. GE Healthcare Cancer Diagnostics Product Offerings
Table 35. GE Healthcare Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott Cancer Diagnostics Product Offerings
Table 38. Abbott Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Cancer Diagnostics Product Offerings
Table 41. Roche Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Thermo Fisher Scientific Corporate Summary
Table 43. Thermo Fisher Scientific Cancer Diagnostics Product Offerings
Table 44. Thermo Fisher Scientific Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Agilent Technologies Corporate Summary
Table 46. Agilent Technologies Cancer Diagnostics Product Offerings
Table 47. Agilent Technologies Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Illumina Corporate Summary
Table 49. Illumina Cancer Diagnostics Product Offerings
Table 50. Illumina Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Siemens Healthcare Corporate Summary
Table 52. Siemens Healthcare Cancer Diagnostics Product Offerings
Table 53. Siemens Healthcare Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. C.R. Bard Corporate Summary
Table 55. C.R. Bard Cancer Diagnostics Product Offerings
Table 56. C.R. Bard Cancer Diagnostics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Diagnostics Segment by Type in 2021
Figure 2. Cancer Diagnostics Segment by Application in 2021
Figure 3. Global Cancer Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Diagnostics Revenue in 2021
Figure 8. By Type - Global Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Becton, Dickinson and Company Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GE Healthcare Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Thermo Fisher Scientific Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Agilent Technologies Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Illumina Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Siemens Healthcare Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. C.R. Bard Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)